In 2025, Innovent launched Xinermei (mazdutide) in China, and ecnoglutide was launched by Sciwind Biosciences in 2026
The answer is simple: Recent Phase 3 trial data showed: Many obesity experts consider these results among the strongest ever reported for a non-surgical obesity treatment

Diverse Biological Activities The peptide's biological activities are remarkably diverse and include stimulation of collagen and glycosaminoglycan synthesis (critical for skin, connective tissue, and wound healing), activation of wound healing mechanisms, promotion of blood vessel formation (angiogenesis) to support tissue repair and regeneration, anti-inflammatory effects that resolve excessive inflammation while supporting beneficial healing responses, antioxidant and protective effects against oxidative damage and toxic compounds, attraction of immune and repair cells to sites of injury, remodeling of extracellular matrix through regulated metalloproteinase activity, stimulation of nerve outgrowth and regeneration, and even modulation of gene expression in patterns that reverse age-related changes and restore more youthful cellular function

Antioxidant properties of PQQ and role in cellular redox balance The mitochondrial metabolism-oriented production of reactive oxygen species (ROS) is a significant contributor to cellular oxidative stress and damage to the biological macromolecules
Many practitioners use it successfully in postmenopausal women
Follow-Up Schedule Your provider will schedule your next injection based on your needs to maintain optimal B12 levels